Tactile Medical Q2 revenue up 45% to $51.1M, net income $1.3M; raises FY guidance low end

TACTILE SYSTEMS TECHNOLOGY INC

2021-Q2 EPS reported -$0.05 revenue$93,832,000

Q2 revenue $51.1M (+45% YoY); net income $1.3M vs loss of $13.9M; diluted EPS $0.07 vs loss of $0.72.
Adjusted EBITDA $4.1M vs loss of $0.7M; operating loss narrowed to $0.1M from $8.0M.
Updated FY2021 revenue guidance: $216.3M–$224.5M (growth 16%–20%), low end raised from prior $215.3M.
Appointed Eric Pauls as SVP of Sales effective May 1, succeeding Bryan Rishe.
Restated credit facility with Wells Fargo: $25M revolving with $30M accordion (up to $55M), replacing $10M facility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.